Literature DB >> 27727254

[Trade of food supplement: food or drug supplement?]

Margherita Siracusa1, Fabio Petrelli1.   

Abstract

The aporia is obvious: food supplement, classified and regulated by food law, sometimes have the characteristics and the typical effects of medicines. In addition, these are produced by pharmaceutical companies and, through the scientific officer, are prescribed by doctors and dispensed by pharmacies. This study will attempt to retrace the winding, and sometimes overlapping, regulatory pathways of the legislation on food supplement, food and medicines. It will be important object the particular application of the precautionary principle behind the legislation on food supplement: application "in posterior", so the controls on the purity of the product and the possible effects resulting from the assumption is carried out ex post trade. So we try to disentangle the intricate legislation with the national (and European) Court contributions. In particular, after a brief analysis of the rulings of the Competition and Market Authority on misleading advertising and by the Supreme Court in relation to crimes against health damage, it will come to the analysis of interpretative problems of a purely criminal law nature, in light of the recent proposal for reform about agribusiness crimes. Finally, it will be inevitable to analyze briefly the recent implementation of the d.lgs. n. 17/2004 concerning the distance trade of non-prescription medicines. There is no doubt that now, internet represents the preferred distribution channel for pharmaceutical products (including food supplement) and the most tempting "place" (because of control difficulties) for the realization of criminal conduct. The conclusion will be that the need to achieve more targeted and homogeneous regulatory measures, while also having to protect - public and individual - health through the protection of the legal security in one with the protection of the right to information.

Mesh:

Year:  2016        PMID: 27727254     DOI: 10.1701/2354.25224

Source DB:  PubMed          Journal:  Recenti Prog Med        ISSN: 0034-1193


  7 in total

1.  A systematic review of pharmacoeconomic evaluations of erlotinib in the first-line treatment of advanced non-small cell lung cancer.

Authors:  Cuc Thi Thu Nguyen; Fabio Petrelli; Stefania Scuri; Binh Thanh Nguyen; Iolanda Grappasonni
Journal:  Eur J Health Econ       Date:  2019-03-06

2.  Training to improve resilience and coping to monitor PTSD in rescue workers.

Authors:  S Scuri; F Petrelli; T T C Nguyen; I Grappasonni
Journal:  J Prev Med Hyg       Date:  2019-03-29

3.  The requirements for manufacturing highly active or sensitising drugs comparing Good Manufacturing Practices.

Authors:  Fabio Petrelli; Alessandro Caraffa; Stefania Scuri; Iolanda Grappasonni; Elena Magrini; Aldo Cocchini
Journal:  Acta Biomed       Date:  2019-05-23

4.  Levels of understanding of the rules of correct medical usage among vietnamese pharmacy students: a cross-sectional study.

Authors:  C T T Nguyen; S Scuri; B T Nguyen; F Petrelli; I Grappasonni
Journal:  J Prev Med Hyg       Date:  2018-12-15

5.  Mental and physical effects of energy drinks consumption in an Italian young people group: a pilot study.

Authors:  F Petrelli; I Grappasonni; D Evangelista; P Pompei; G Broglia; P Cioffi; L Kracmarova; S Scuri
Journal:  J Prev Med Hyg       Date:  2018-03-30

6.  Lifestyles and discomfort in a sample of young Romanian students.

Authors:  F Petrelli; S Scuri; E Tanzi; T T C Nguyễn; I Grappasonni
Journal:  J Prev Med Hyg       Date:  2018-09-28

7.  The economic crisis and lifestyle changes: a survey on frequency of use of medications and of preventive and specialistic medical care, in the Marche Region (Italy).

Authors:  Iolanda Grappasonni; Stefania Scuri; Elisabetta Tanzi; Lenka Kracmarova; Fabio Petrelli
Journal:  Acta Biomed       Date:  2018-03-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.